Concepedia

Publication | Open Access

A phase Ib trial of lenvatinib (LEN) plus pembrolizumab (PEMBRO) in unresectable hepatocellular carcinoma (uHCC): Updated results

DOIFull Paper Access

67

Citations

0

References

2019

Year

Josep M. Llovet, Karen Shepard, RS Finn, Masafumi Ikeda, Max W. Sung, Ari David Baron, Masatoshi Kudo, Takuji Okusaka, Masahiro Kobayashi, H. Kumada,
Annals of Oncology

No additional data available for this publication yet. Check back later!